BioCentury
ARTICLE | Company News

Trophos, Roche deal

January 19, 2015 8:00 AM UTC

Roche will acquire Trophos for ÿ120 million ($142 million) up front and up to ÿ350 million ($414 million) in milestones. Roche gains olesoxime, a small molecule with cholesterol-like structure that in...